nasdaq:zlab
|
7797446
|
Mar 23rd, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 23rd, 2024 01:05AM
|
Mar 23rd, 2024 07:37PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 22nd, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 22nd, 2024 12:38AM
|
Mar 22nd, 2024 07:25PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 21st, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 21st, 2024 06:09PM
|
Mar 21st, 2024 06:09PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 20th, 2024 12:00AM
|
Zai Lab
|
24K
|
528.00
|
Open
|
|
Mar 20th, 2024 02:48AM
|
Mar 20th, 2024 08:10PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 19th, 2024 12:00AM
|
Zai Lab
|
24K
|
528.00
|
Open
|
|
Mar 19th, 2024 01:55AM
|
Mar 19th, 2024 06:42PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 18th, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 18th, 2024 12:58AM
|
Mar 18th, 2024 07:55PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 16th, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 15th, 2024 11:58PM
|
Mar 16th, 2024 07:42PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 15th, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 15th, 2024 07:37AM
|
Mar 15th, 2024 09:33AM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 14th, 2024 12:00AM
|
Zai Lab
|
24K
|
529.00
|
Open
|
|
Mar 13th, 2024 11:58PM
|
Mar 14th, 2024 12:55PM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|
nasdaq:zlab
|
7797446
|
Mar 13th, 2024 12:00AM
|
Zai Lab
|
24K
|
530.00
|
Open
|
|
Mar 12th, 2024 11:51PM
|
Mar 13th, 2024 11:25AM
|
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
|
Open
|
|
Open
|
4560 Jinke Road
|
Zhangjiang Hi-tech Park, Pudong
|
Shanghai
|
CN
|
201210
|
|
Zai Lab
|
|
|